Sowell Financial Services LLC Fibrogen Inc Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$18.57 - $35.68 $42,562 - $81,778	-2,292 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$31.0 - $55.72 $15,934 - $28,640	-514 Reduced 18.32%	2,292 $47,000
Q4 2020 Jan 13, 2021	BUY	$37.09 - $48.97 $93,615 - $123,600	2,524 Added 895.04%	2,806 $104,000
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $3,439 - $3,867	85 Added 43.15%	282 $12,000
Q1 2020 May 12, 2020	SELL	$23.3 - $45.96 $675 - $1,332	-29 Reduced 12.83%	197 $7,000
Q4 2019 Feb 07, 2020	BUY	$34.58 - $48.06 $5,636 - $7,833	163 Added 258.73%	226 $9,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $2,329 - $3,052	63 New	63 $2,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $36.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.